0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Preliminary results show Covaxin has an efficacy of 81% in phase 3 clinical trial.
Share this article
If you liked this article share it with your friends.they will thank you later